The Future of Cardiac Magnetic Resonance: Navigating Ultra-High and Low-Field Imaging (Part 2) [0.03%]
心脏磁共振的未来：超高效和低场 imaging（第二部分）
Nicole Seiberlich,Jeanette Schulz-Menger,Sebastian Schmitter et al.
Nicole Seiberlich et al.
While clinical cardiac magnetic resonance (CMR) is performed on 1.5T and 3T MR imaging systems, high-field and low-field scanners operating at field strengths including 7T and 0.55T have been explored for CMR. These less common systems have...
Geraldine Villasana Gomez,Cameron Denley,Panagiota Christia
Geraldine Villasana Gomez
Cardiovascular disease remains the leading cause of morbidity and mortality worldwide, underscoring the need for accurate, efficient, and widely accessible diagnostic imaging. Cardiac MR imaging (CMR) is considered the reference standard fo...
Climate Change and Globally Sustainable Cardiovascular Magnetic Resonance [0.03%]
气候变化与全球可持续性心血管磁共振技术
Nicole Bodnariuc,Michael Markl,Tessa Cook et al.
Nicole Bodnariuc et al.
Climate change is driving increased cardiovascular risk and demand for medical imaging. While cardiovascular magnetic resonance (CMR) plays a critical role in diagnosing and managing cardiovascular disease, it is also among the most environ...
Dena E Hayes,Gabriella Bayshtok,Jadranka Stojanovska et al.
Dena E Hayes et al.
Strain imaging, performed with echocardiography and cardiovascular magnetic resonance (CMR), is a noninvasive technique for detecting subclinical myocardial dysfunction across the heart failure spectrum, in various cardiomyopathies, and wit...
Cardiovascular Magnetic Resonance in Detecting Cardiovascular Involvement in Systemic Inflammatory Disease: Focus on Inflammatory Bowel Disease, Obesity, and Systemic Sclerosis [0.03%]
炎症性肠病、肥胖和系统性硬化症等全身性炎症性疾病心血管受累的心血管磁共振检测:focus on inflammatory bowel disease, obesity, and systemic sclerosis)
Planinka Zafirovska,Viseslav Popadic,Maja Popovic et al.
Planinka Zafirovska et al.
Chronic systemic inflammation is increasingly recognized as a key contributor to cardiovascular disease, autoimmune disorders, and metabolic syndromes. Systemic inflammatory conditions share common pathophysiological pathways leading to myo...
Cardiovascular Involvement in Autoimmune Rheumatic Diseases: Evaluation Using Cardiovascular MR Imaging [0.03%]
自身免疫性风湿病的心血管受累：使用心血管磁共振成像评估
George Markousis-Mavrogenis,George D Kitas,Petros P Sfikakis et al.
George Markousis-Mavrogenis et al.
One-third of the mortality in autoimmune rheumatic diseases (ARDs) is due to cardiovascular disease (CVD). CVD in ARDs includes: (1) macro- or microvascular coronary artery disease (CAD), (2) inflammatory cardiomyopathy, due to myocardial m...
Cardiac MR Imaging of Flow Abnormalities in Hypertrophic Cardiomyopathy Phenotypes [0.03%]
肥厚型心肌病表型的血流异常心血管磁共振成像
Kana Fujikura,Mark V Sherrid,Daniele Massera et al.
Kana Fujikura et al.
MR imaging is increasingly used in evaluation of patients with known or suspected hypertrophic cardiomyopathy (HCM), as it provides useful information on cardiac structure, function, and tissue characterization that is complementary to echo...
Ranjini Srinivasan,Alessandro Castiglione,Michael Antonchak et al.
Ranjini Srinivasan et al.
Right ventricular (RV) enlargement or dysfunction evaluation is the cornerstone for diagnosis, prognostications, and treatment planning in a variety of cardiovascular conditions. Cardiac MR imaging (CMR) is the superior imaging modality for...
Cardiovascular MR in Cardiac Amyloidosis: Part II-Clinical Applications in Diagnosis, Prognosis, and Treatment Response [0.03%]
心脏淀粉样变的心脏磁共振检查（二）——诊断、预后及治疗反应中的临床应用
Chi Yang Chen,Jose Alvarez-Cardona,Ana Barac
Chi Yang Chen
Although adoption of noninvasive cardiac scintigraphy has transformed the diagnosis of transthyretin cardiac amyloidosis, significant challenges remain, particularly in indeterminate scintigraphy findings, light chain amyloidosis, and rare ...
Cardiovascular Magnetic Resonance in Cardiac Amyloidosis: Part I-Technical Foundations, Techniques, and Endpoints [0.03%]
心脏淀粉样变心血管磁共振（上篇）：技术基础、方法及观察指标
Chi Yang Chen,Jose Alvarez-Cardona,Ana Barac
Chi Yang Chen
Amyloidosis is a systemic disease characterized by the extracellular deposition of the misfolded proteins resulting in organ dysfunction, frequently the heart. Cardiac amyloidosis is an underrecognized cause of heart failure which carries s...